NCT03055624View on ClinicalTrials.gov

Prostate Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

February 18, 2019

Study Completion Date

February 18, 2019

Conditions
Prostatic Hyperplasia, BenignEnlarged Prostate With Lower Urinary Tract Symptoms
Interventions
DEVICE

Embosphere microparticles for prostate artery embolization

Pelvic angiograms will be performed and microspheres delivered to the arteries supplying the prostate to alleviate symptoms of benign prostatic hyperplasia.

Trial Locations (1)

92007

University of California San Diego, San Diego

All Listed Sponsors
lead

University of California, San Diego

OTHER

NCT03055624 - Prostate Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia | Biotech Hunter | Biotech Hunter